HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2417004Generated: November 1, 2026
1H-Imidazo(4,5-c)pyridine → 1-(4-nitro-naphthalen-1-yl)-1H-imidazo[4,5-c]pyridine
https://huagongshe.com/reaction/2417004
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1H-Imidazo(4,5-c)pyridine | HCID 9227 | — |
| Reactant | 1-Fluoro-4-nitronaphthalene | HCID 261764 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | 1-(4-nitro-naphthalen-1-yl)-1H-imidazo[4,5-c]pyridine | HCID 22631406 | — |
Reaction Steps
5-Aza-benzimidazole (312 mg, 2.62 mmol, 1 equiv.) in 5 mL anhydrous DMSO was treated with potassium tert-butoxide (294 mg, 2.62 mmol, 1.0 equiv.) at room temperature. When the mixture was completely homogeneous, 4-fluoro-1-nitro-naphthalene (500 mg, 2.62 mmol, 1 equiv.) was added in one portion and the mixture was heated to 60° C. for 0.5 h. The reaction was allowed to cool, then quenched with dilute aqueous NaHCO3 solution. The product was extracted with a mixture of EtOAc, THF and acetone. The organic extracts were washed with water and brine, then dried (Na2SO4), filtered and the solvents removed in vacuo. 1H NMR revealed a 1:1 ratio of regioisomers. The products were purified by column chromatography on SiO2 using EtOAc/MeOH eluent mixtures. 1-(4-Nitro-naphthalen-1-yl)-1H-imidazo[5,4-c]pyridine was isolated at high Rf and 1-(4-nitro-naphthalen-1-yl)-1H-imidazo[4,5-c]pyridine at lower Rf, and overlapping fractions were in between. The overall yield was 357 mg (47%). Each nitro-naphthalene from above (˜100 mg, 0.4 mmol) was separately dissolved in 10 mL EtOAc and 5 mL of MeOH. Ammonium formate was then added (100 mg, 1.6 mmol or 4 equiv.) and 10% palladium-on-carbon (˜60 mg). The mixture was stirred for 0.5 h at 50° C., then allowed to cool, filtered through diatomaceous earth and the solvents were removed in vacuo to afford ˜80 mg of each naphthyl-amine 5a and 5b, which could be coupled with anilines or pyrazolamines to form ureas by the procedures described in Examples 2-4 above.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06825184B2 |
|---|
| Source dataset | uspto-grants-2004_11 |
|---|
| ORD ID | ord-5a8a6e70808b403c9ee25e6c64ef11df |
|---|
| Source note | uspto-grants-2004_11 |
|---|